A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
